Wells Fargo
PRVL

Wells Fargo’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Wells Fargo’s Portfolio PRVL Stock Details PRVL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
2020
Q4 		$749K Buy
2020
Q3 		$97K Sell
2020
Q2 		$166K Sell
2020
Q1 		$260K Buy
2019
Q4 		$192K Buy
2019
Q3 		$55K Buy